COVID-19: This Is When Americans Will Need Third Shot, Scientist Says

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
COVID-19: This Is When Americans Will Need Third Shot, Scientist Says

© Pool / Getty Images News via Getty Images

The rate of the spread of COVID-19 had slowed across America. Despite a new surge, increases in daily fatal and confirmed cases are still about half what they were three months ago. Nevertheless, 573,551 Americans had died as of Tuesday, which is about 20% of the world’s total. The global death total just moved above a staggering 3 million. Confirmed cases have reached 31,976,092 in the United States, or about 23% of the global number. Hospitalizations, which were over 100,000 a day during the peak wave, have dropped into the thousands.
[in-text-ad]
Variants have become a large part of the conversation among public health officials and epidemiologists. One variant, first identified in the United Kingdom and known as B.1.1.7, is more transmissible than the strain that was dominant in the United States over most of the pandemic. The Centers for Disease Control and Prevention (CDC) also officially tracks these other variants: B.1.351, P.1, B.1.427 and B.1.429. Worries are that some may be more deadly than others and that vaccines may not protect against one or more variants.

Scientists believe that new variants will continue to appear, some of which may originate in America and others that may come from overseas. Tuesday, it was announced that “Scientists at the Texas A&M University Global Health Research Complex (GHRC) have identified a variant of the COVID-19 virus — ‘BV-1’ — that could present a new challenge to public health.”
[nativounit]
At this point, according to The New York Times, 40% of Americans have been given at least one dose of a vaccine, and 26% are fully vaccinated. As of Wednesday, 277,938,875 doses have been delivered, and from those 215,951,909 shots have been given, or about 78%.

There has been a debate among scientists and doctors about when people will need additional doses. Some of this has to do with how effective vaccines are against variants. A week ago, Pfizer CEO Albert Bourla said that people would likely need a third dose within 12 months of being vaccinated.

Bourla’s opinion was supported Wednesday by Dr. Ozlem Tureci, the chief medical officer of BioNTech, which helped Pfizer develop its vaccine. She commented to CNBC:

… people will need to get vaccinated against the coronavirus annually, like for the seasonal flu. That’s because, she said, scientists expect vaccine-induced immunity against the virus will decrease over time.

The Pfizer vaccine now is given in two doses.

That means almost 300 million Americans will need another dose, almost certainly late this year or early next.

Click here to read “Living Through One Year Of COVID-19.”
[wallst_email_signup]

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618